massarraytm platform (Genaissance Pharmaceuticals)
90
Structured Review
Genaissance Pharmaceuticals
massarraytm platform
Massarraytm Platform, supplied by Genaissance Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarraytm+system/massarraytm+platform/pm18320559-53-11-4
Average 90 stars, based on 1 article reviews
Massarraytm Platform, supplied by Genaissance Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarraytm+system/massarraytm+platform/pm18320559-53-11-4
Average 90 stars, based on 1 article reviews
massarraytm platform - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Dopamine receptor D3 genotype association with greater acute positive symptom remission with olanzapine therapy in predominately caucasian patients with chronic schizophrenia or schizoaffective disorder. Article Snippet: Objective To test association of dopamine receptor D3 (DRD-3) gene polymorphisms with olanzapine response in genetic samples from a registration phase clinical trial.. Methods Eighty-eight acutely ill patients with schizophrenia or schizoaffective disorder were genotyped for ser-9-gly (rs6280) and 23 other polymorphisms within the DRD-3 gene.. Allelic association of clinical response (mean baselineto-endpoint reduction in Positive and Negative Syndrome Scale [PANSS] total and subscores) over 6 weeks of olanzapine treatment was assessed using repeated measures analysis of variance. |